8+ hour, 6+ min ago   (115+ words) Access to medicines is under pressure across the EU, as rising prices for new therapies and growing demand test the limits of public budgets. Between 2020 and 2025, Member States implemented wide-ranging reforms to expand coverage, reduce out-of-pocket costs, and sustain innovation....

17+ hour, 27+ min ago   (68+ words) Trial results offers new hope for heart patients sentinelnews.com.au Trial results offers new hope for heart patients Ramping falls to six-year low The rise of anti-vaccine activism and the fall of child immunisation Sardinemaxxing is no fishy fad…...

20+ hour, 51+ min ago   (323+ words) — Quotable quotes heard by MedPage Today's reporters "The underlying case is a real-but-vanilla commercial dispute." -- Christopher Robertson, JD, PhD, of Boston University, discussing a medical software company's lawsuit against a former collaboratoropens in a new tab or window, who helped…...

1+ day, 5+ hour ago   (458+ words) A $300,000 mansion and a lab for “their own”: State Medicines Service liquidated and new agency created АНТИКОР - A $300,000 mansion and a lab for?their own?: State Medicines Service liquidated and new agency created This is reported by Glavcom. The previous…...

1+ day, 3+ hour ago   (985+ words) The Democratic Republic of Congo reports a surge in Ebola cases, now exceeding 7,000, with the outbreak spreading to a seventh province, South Ubangi. Government data highlights the expanding crisis. In the U.S., authorities declared the end of a significant cyclosporiasis outbreak…...

1+ day, 3+ hour ago   (205+ words) Health Headlines: Epidemics, Legal Battles, and Big Pharma Moves Devdiscourse Health Headlines: Epidemics, Legal Battles, and Big Pharma Moves The Democratic Republic of Congo sees Ebola cases surpass 7,000. The U.S. ends its largest cyclosporiasis outbreak, while Bayer faces a court test…...

22+ hour, 36+ min ago   (295+ words) Cancer. Diabetes. Aging itself. Rapamycin’s potential to treat an array of diseases has been a source of scientific fascination. But many aren’t aware of its origins – and its complicated legacy....

1+ day, 3+ hour ago   (323+ words) Last week’s regulatory news saw the US Food and Drug Administration (FDA) grant accelerated approval for AstraZeneca’s Etcamah combination for the treatment of breast cancer. On the research front, Novartis suffered another setback, this time with its Phase III trial…...

1+ day, 2+ hour ago   (586+ words) Following large-scale searches in the case involving the counterfeiting and distribution of the weight-loss drug “Biopatid,” questions have arisen regarding the future course of the investigation, the completeness of the evidence seized, the conduct of forensic examinations, and the seizure…...

1+ week, 3+ day ago   (335+ words) FDA further tests waters on AI medical devices; Ultragenyx sees its stock crater on Phase 3 trial failure; Brain implants take center stage in U.S.-China biotech race. The Food and Drug Administration is letting some generative-AI medical devices reach patients before…...